Stay updated on Pembrolizumab Combo in Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:46:25.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Sponsor-related content and external data-sharing links were removed from the page, including Merck branding, IPD sharing URLs, and references to study documents.
    Difference
    20%
    Check dated 2026-09-23T00:36:39.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision: v3.7.0 is now shown on the page, replacing the previous Revision: v3.6.6. This indicates an updated page revision of the study details.
    Difference
    0.0%
    Check dated 2026-09-15T23:49:15.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6, signaling a backend/software update rather than changes to the study information presented.
    Difference
    0.0%
    Check dated 2026-09-01T19:48:02.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    A new NIH funding entry for 2018 was added to the study's identifiers. This updates the record to reflect U.S. NIH support for KEYNOTE-799.
    Difference
    0.0%
    Check dated 2026-08-25T19:49:58.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.4 to v3.6.5, signaling a minor update to the page's build. This does not modify the study details or other user-visible content.
    Difference
    0.0%
    Check dated 2026-08-11T19:30:10.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Stage III NSCLC Clinical Trial page.